Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI™ ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients

被引:39
|
作者
Mazzaferro, Sandro [1 ]
Pasquali, Marzia [1 ]
Farcomeni, Alessio [2 ]
Vestri, Anna Rita [2 ]
Filippini, Angelo [3 ]
Romani, Anna Maria [3 ]
Barresi, Giusi [1 ]
Pugliese, Francesco [1 ]
机构
[1] Sapienza Univ, Dept Clin Sci, I-00161 Rome, Italy
[2] Sapienza Univ, Dept Expt Med, I-00161 Rome, Italy
[3] Sapienza Univ, Dept Surg Sci, I-00161 Rome, Italy
关键词
NKF-K/DOQI guidelines; parathyroid hormone; parathytroidectomy; secondary hyperparathyroidism;
D O I
10.1093/ndt/gfm931
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. The recommended NKF-K/DOQI'99 ranges for Ca, P and PTH in dialysis seem advisable also for patients previously submitted to parathyroidectomy; however no paper addresses, specifically in this condition, to what extent optimal values are targeted in the short and long term after surgery. Methods. We checked serum Ca, P and PTH basally and after 1 month and 1, 3 and 5 years since surgery, in 77 dialysis subjects who received parathyroidectomy in our hospital. Results. Immediately after surgery all biochemical para- meters dropped, but afterwards Ca showed a tendency to increase progressively in the long term (p <.0006), P increased mostly within one year (p <.01), and PTH increased similarly to Ca (p <.003), but with mean values always in the lower than desired range. The estimated percentage of patients at target during the follow-up was maximal for P (values between 65 and 76%), lower for Ca (zenith of 43% after 1 month but declining down to 14% after 5 years) and minimal for PTH (invariably < 10%). Persistence within the ranges (at least on two consecutive checks) was 21% after one month for Ca, with a tendency to reduction; 41% for P, with a tendency to average roughly 30%, and practically zero for PTH. Neither type of surgery (total or subtotal) nor vitamin D therapy were associated with the low values of PTH observed. Conclusions. We conclude that parathyroid surgery does not represent an optimal therapeutic tool for targeting the recommended ranges for Ca, P and PTH. In particular, too low PTH values are frequently obtained, whose clinical effects deserve further studies. The possibility of a time dependent risk for recurrence is confirmed.
引用
收藏
页码:2319 / 2323
页数:5
相关论文
共 39 条
  • [1] Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism
    Kovacevic, Bojan
    Ignjatovic, Mile
    Zivaljevic, Vladan
    Cuk, Vladimir
    Scepanovic, Milena
    Petrovic, Zaklina
    Paunovic, Ivan
    LANGENBECKS ARCHIVES OF SURGERY, 2012, 397 (03) : 413 - 420
  • [2] Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism
    Bojan Kovacevic
    Mile Ignjatovic
    Vladan Zivaljevic
    Vladimir Cuk
    Milena Scepanovic
    Zaklina Petrovic
    Ivan Paunovic
    Langenbeck's Archives of Surgery, 2012, 397 : 413 - 420
  • [3] K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?
    Wei, Mingxin
    Taskapan, Hulya
    Esbaei, Khaled
    Jassal, Sarbjit Vanita
    Bargman, Joanne M.
    Oreopoulos, Dirnitrios G.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2006, 38 (3-4) : 739 - 743
  • [4] K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?
    Mingxin Wei
    Hulya Taskapan
    Khaled Esbaei
    Sarbjit Vanita Jassal
    Joanne M. Bargman
    Dimitrios G. Oreopoulos
    International Urology and Nephrology, 2006, 38 : 739 - 743
  • [5] Cinacalcet (MIMPARA®/SENSIPAR®) maintains achievement of NKF-K/DOQI treatment targets for secondary hyperparathyroidism (HPT) in patients on dialysis
    Frazao, JM
    Holzer, H
    Stummvoll, HK
    Bahner, U
    Wilkie, M
    Zani, V
    Hutton, H
    Motellon, JL
    Braun, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V89 - V89
  • [6] Attainment of proposed NKF-K/DOQI PTH and calcium x phosphorus targets is associated with decreased mortality risk in hemodialysis patients
    Walters, BAJ
    Nabut, J
    Danese, MD
    Kim, JJ
    Klassen, PS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 47A - 48A
  • [7] Achievement of proposed NKF-K/DOQI bone metabolism and disease targets: Treatment with cinacalcet HCl in dialysis patients with uncontrolled secondary hyperparathyroidism (HPT)
    Moe, SM
    Coburn, JW
    Quarles, LD
    Goodman, WG
    Chertow, GM
    Block, GA
    Drueke, T
    Cunningham, J
    Sherrard, DJ
    McCary, LC
    Olson, KA
    Turner, SA
    Martin, KJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 48A - 48A
  • [8] Achievement of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative: recommended serum calcium, phosphate and parathyroid hormone values with parathyroidectomy in patients with secondary hyperparathyroidism
    Kim, Woo Young
    Lee, Jae Bok
    Kim, Hoon Yub
    Woo, Sang Uk
    Son, Gil Soo
    Bae, Jeoung Won
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2013, 85 (01): : 25 - 29
  • [9] TO TARGET STUDY: INTERIM ANALYSIS OF A SINGLE-ARM STUDY TO ASSESS ACHIEVEMENT OF NKF-K/DOQI MINERAL METABOLISM TARGETS IN AUSTRALIAN DIALYSIS PATIENTS USING SENSIPAR®
    Masterson, R.
    Talaulikar, G.
    Mantha, M.
    Jones, B.
    Bannister, K.
    Tolman, C.
    Manamley, N.
    NEPHROLOGY, 2008, 13 : A148 - A148
  • [10] Can Calcium, Phosphate, Calcium Phosphate Product and Intact Parathyroid Hormone Levels Be Appropriately Controlled in Dialysis Patients?
    Deger, S. M.
    Mutluay, R.
    Derici, U.
    Mandiralioglu, F.
    Arinsoy, T.
    Sindel, S.
    MEDICAL PRINCIPLES AND PRACTICE, 2011, 20 (01) : 85 - 89